Wall Street's Romance with Cannabis Is Getting Serious

 You are receiving this as part of your subscription to Cannabis Profits Daily. To remove your email from this list, [unsubscribe here](.  [Cannabis Profits Daily]( Tuesday, September 17, 2019 [U.S. Cannabis Companies Receive Crucial Recognition from Cowen]( By Greg Miller Vivien Azer - the Managing Director of Cowen Inc. (Nasdaq: [COWN]() - may have started a huge wave of new investments in the cannabis industry. She's a formidable analyst who just predicted Cresco Labs Inc. (CSE: [CL](, OTC: [CRLBF](), Green Thumb Industries (CSE: [GTII](, OTC: [GTBIF](), and Curaleaf Holdings Inc. (CSE: [CURA](, OTC: [CURLF]() would outperform the market. She expects Acreage Holdings (CSE: [ACRG](, OTC: [ACRGF]() to perform with the market and MedMen Enterprises Inc. (CSE: [MMEN](, OTC: [MMNFF]() to underperform. Anyone should at least read her report, even if they end up disagreeing with her. But the big news isn't that she just rated cannabis stocks. It's that these are U.S. cannabis companies that "touch the leaf," and that Cowen was willing to rate them. As best I can tell, this is the very first time that a major Wall Street firm has rated stocks that are technically in violation of U.S. law. Previously, Ms. Azer and her counterparts at Merrill Lynch, Jefferies, Piper Jaffrey, and other Wall Street companies only rated "fully" legal companies. That means producers in Canada and U.S. companies that did not touch cannabis directly, like KushCo Holdings Inc. (OTC: [KSHB](). I've previously written that these Wall Street firms would not begin to cover the U.S. participants until there was some movement by the federal government towards legalization. Azer and the compliance team at Cowen proved me wrong. [And I'm going to tell you why I couldn't be happier...]( [trending] [Your IPO Dossiers Are Waiting: Learn How to Get Immediate Access]( Analysts at the National Institute for Cannabis Investors have compiled in-depth reports on six companies that could go public any day now - and this is info you'll want to see before that happens. [Read more]( [Shifting Legal Landscape Forces Cannabis Business Model Evolution]( Cannabis companies shouldn't rely too heavily on limited licenses to restrict competition... [Read more]( [Private Enterprise Boosts California's Legal Marijuana Profits]( This one company can do more to move California's marijuana profits into the legal light than any politician in the state... [Read more]( [top video] Learn How to Save Time and Take Your Profit Potential to the Max With new cannabis companies popping up on weekly - if not daily - basis, it can be hard to find the time to do the kind of in-depth research required to make a smart investment. That's where our [NICILytics database]( can come in handy. We created [this one-of-a-kind investing tool]( to help you make well-informed decisions when it comes to the cannabis market. There's no longer any need to blindly invest in cannabis companies or spend hours doing your own research... because we have everything you need to know about over 190 cannabis companies. [Learn how to get immediate access here](. [WATCH]( [our feature benefits] The CBD market is on fire. Little-known companies are raking in an absolute profit - like Isodiol International, a provider of high-quality CBD and hemp products. In fact, our data shows that if you had invested in this company in July and August of last year, you could have watched your holdings soar as much as [1,185% in just 34 days](. And that's only the beginning - this market sector is currently projected to hit $22 BILLION in sales by 2022. That's why our experts have identified [two breakout CBD companies]( that could turn a grubstake into an absolute fortune... and you can get started for under $3. To learn how, [click here](. [JOIN NOW]( [stay connected] [facebook]( [twitter]( [instagram]( [National Institute for Cannabis Investors] You are receiving this e-mail at {EMAIL}, as a part of your subscription to Cannabis Profits Daily. Remove your email from this list: [Unsubscribe]( © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 [Contact Customer Service](mailto:support@nicinvestors.com?subject=Cannabis%20Profits%20Daily%20Question) Website: []( Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. [Privacy Policy]( | [Terms & Conditions](